Study assessing its potential for COVID-19 discontinued due to feasibility of recruitment More: Novartis pulls plug on hydroxychloroquine trial Source: News
read moreA new version of the Code is expected to come into force in July 2021 More: ABPI consults on 'new-look' Code of Practice Source: News
read moreThe regulator will assess its safety and efficacy as a treatment for bladder cancer More: EMA to consider expanding use of Merck/Pfizer's Bavencio Source: News
read morePfizer’s blockbuster-to-be Vyndaqel is too costly for heart patients, study suggests aliu Fri, 06/19/2020 – 11:05 More: Pfizer's blockbuster-to-be Vyndaqel is too costly for heart patients, study suggests Source: fierce
read moreGlaxoSmithKline recalls children’s Robitussin, Dimetapp with faulty dosing cups kblankenship Fri, 06/19/2020 – 11:04 More: GlaxoSmithKline recalls children's Robitussin, Dimetapp with faulty dosing cups Source: fierce
read moreJohnson & Johnson in talks to supply COVID-19 vaccine in Europe: reports esagonowsky Fri, 06/19/2020 – 10:09 More: Johnson & Johnson in talks to supply COVID-19 vaccine in Europe: reports Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals